Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study

Clinical trial NCT02792478 · COMPLETED

Trial details

NCT number: NCT02792478
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

RAS Wild Type mCRC

Start date: 2016-05-06
Primary completion: 2021-05-31
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.